Placental endocrine function

Knobil and Neill's Physiology of Reproduction

Volumn , Issue , 2006, Pages 2847-2897

  Petraglia, Felice ^a   Florio, Pasquale ^a   Torricelli, Michela ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650502467     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012515400-0/50058-0     Document Type: Chapter

References (452)

1. Petraglia F., Florio P., Nappi C., Genazzani A.R. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr. Rev. 1996, 17:156-186.
2. Reis F.M., Petraglia F. The placenta as a neuroendocrine organ. Front. Horm. Res. 2001, 27:216-228.
3. Stojilkovic S.S., Reinhart J., Catt K.J. Gonadotropin-releasing hormone receptors: structure and signal transduction pathways. Endocr. Rev. 1994, 15:462-499.
4. Khodr G.S., Siler-Khodr T.M. Localization of luteinizing hormone-releasing factor in the human placenta. Fertil. Steril. 1978, 29:523-530.
5. Khodr G.S., Silver-Khodr T.M. Placental luteinizing hormone-releasing and its synthesis. Science 1980, 207:315-317.
6. Tan L., Rousseau P. The chemical identity of the immunoreactive LHRH-like peptide biosynthesized in the human placenta. Biochem. Biophys. Res. Commun. 1982, 109:1061-1071.
7. Wolfahrt S., Kleine B., Rossmanith W.G. Detection of gonadotrophin releasing hormone and its receptor mRNA in human placental trophoblasts using in-situ reverse transcription-polymerase chain reaction. Mol. Hum. Reprod. 1998, 4:999-1006.
8. Miyake A., Sakumoto T., Aono T., Kawamura Y., Maeda T., Kurachi K. Changes in luteinizing hormone-releasing hormone in human placenta throughout pregnancy. Obstet. Gynecol. 1982, 60:444-449.
9. Seppala M., Wahlstrom T., Lehtovirta P., Lee J.N., Leppalouto J. Immunohistochemical demonstration of luteinizing hormone-releasing factor-like material in human syncytiotrophoblast and trophoblastic tumours. Clin. Endocrinol. (Oxf) 1980, 12:441-451.
10. Siler-Khodr T.M., Khodr G.S. Content of luteinizing hormone-releasing factor in the human placenta. Am. J. Obstet. Gynecol. 1978, 130:216-219.
11. Kelly A.C., Rodgers A., Dong K.W., Barrezueta N.X., Blum M., Roberts J.L. Gonadotropin-releasing hormone and chorionic gonadotropin gene expression in human placental development. DNA Cell Biol 1991, 10:411-421.
12. Leung P.C., Peng C. Gonadotropin-releasing hormone receptor: gene structure, expression and regulation. Biol. Signals 1996, 5:63-69.
13. Lin L.S., Roberts V.J., Yen S.S. Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J. Clin. Endocrinol. Metab. 1995, 80:580-585.
14. Boyle T.A., Belt-Davis D.I., Duello T.M. Nucleotide sequence analyses predict that human pituitary and human placental gonadotropin-releasing hormone receptors have identical primary structures. Endocrine 1998, 9:281-287.
15. Yin H., Cheng K.W., Hwa H.L., Peng C., Auersperg N., Leung P.C. Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines. Life Sci 1998, 62:2015-2023.
16. Lamharzi N., Halmos G., Armatis P., Schally A.V. Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines. Int. J. Oncol. 1998, 12:671-675.
17. Cheng K.W., Nathwani P.S., Leung P.C. Regulation of human gonadotropin-releasing hormone receptor gene expression in placental cells. Endocrinology 2000, 141:2340-2349.
18. Kang S.K., Tai C.J., Cheng K.W., Leung P.C. Gonadotropin-releasing hormone activates mitogen-activated protein kinase in human ovarian and placental cells. Mol. Cell. Endocrinol. 2000, 170:143-151.
19. Bramley T.A., McPhie C.A., Menzies G.S. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: I. Characterization, properties and ligand specificity. Placenta 1992, 13:555-581.
20. Bramley T.A., McPhie C.A., Menzies G.S. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: III. Changes in GnRH binding levels with stage of gestation. Placenta 1994, 15:733-745.
21. Iwashita M., Kudo Y., Shinozaki Y., Takeda Y. Gonadotropin-releasing hormone increases serum human chorionic gondotropin in pregnant women. Endocr. J. 1993, 40:539-544.
22. Siler-Khodr T.M., Khodr G.S., Valenzuela G. Immunoreactive gonadotropin-releasing hormone level in maternal circulation throughout pregnancy. Am. J. Obstet. Gynecol. 1984, 150:376-379.
23. Petraglia F., Genazzani A.D., Aguzzoli L., Gallinelli A., De Vita D., Caruso A., Genazzani A.R. Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women. Acta Obstet. Gynecol. Scand. 1994, 73:284-289.
24. Gohar J., Mazor M., Leiberman J.R. GnRH in pregnancy. Arch. Gynecol. Obstet. 1996, 259:1-6.
25. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
26. Warren W.B., Silverman A.J. Cellular localization of corticotrophin releasing hormone in the human placenta, fetal membranes and decidua. Placenta 1995, 16:147-156.
27. Petraglia F., Tabanelli S., Galassi M.C., Garuti G.C., Mancini A.C., Genazzani A.R., Gurpide E. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. J. Clin. Endocrinol. Metab. 1992, 74:1427-1431.
28. Shibasaki T., Odagiri E., Shizume K., Ling N. Corticotropin releasing factor-like activity in human placental extracts. J. Clin. Endocrinol. Metab. 1982, 55:384-386.
29. Sasaki A., Tempst P., Lotta A.S., Margioris A.N., Hood L.E., Kent S.B., Sato S., Shinkawa O., Yoshinaga K., Krieger D.T. Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J. Clin. Endocrinol. Metab. 1988, 67:768-773.
30. Schulte H.M., Healy D.L. Corticotropin releasing hormone- and adreno-corticotropin-like immunoreactivity in human placenta, peripheral and uterine vein plasma. Horm. Metab. Res. 1987, 16:44-46.
31. Frim D.M., Emanuel R.L., Robinson B.G., Smas C.M., Adler G.K., Majzoub J.A. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J. Clin. Invest. 1988, 82:287-292.
32. Grino M., Chrousos G.P., Margioris A.N. The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun. 1987, 148:1208-1214.
33. Warren W.B., Silverman A.J. Cellular localization of corticotrophin releasing hormone in the human placenta, fetal membranes and decidua. Placenta 1995, 16:147-156.
34. Petraglia F., Sawchenko P.E., Rivier J., Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987, 328:717-719.
35. Riley S.C., Challis J.R. Corticotropin-releasing hormone production by the placenta and fetal membranes. Placenta 1991, 12:105-119.
36. Florio P., Rossi M., Sigurdardottir M., Ciarmela P., Luisi S., Vigano P., Grasso D., Fiore G., Cobellis L., Di Blasio A.M., Petraglia F. Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A. Steroids 2003, 68:801-807.
37. Ferrari A., Petraglia F., Gurpide E. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J. Steroid Biochem. Mol. Biol. 1995, 54:251-255.
38. Ahmed I., Glynn B.P., Perkins A.V., Castro M.G., Rowe J., Morrison E., Linton E.A. Processing of procorticotropin-releasing hormone (pro-CRH): molecular forms of CRH in normal and preeclamptic pregnancy. J. Clin. Endocrinol. Metab. 2000, 85:755-764.
39. Goland R.S., Conwell I.M., Jozak S. The effect of pre-eclampsia on human placental corticotrophin-releasing hormone content and processing. Placenta 1995, 16:375-382.
40. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Vale W.W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
41. Petraglia F., Florio P., Gallo R., Simoncini T., Giuntini A., Genazzani A.R. Human placenta and fetal membranes express human urocortin mRNA and peptide. J. Clin. Endocrinol. Metab. 1996, 81:3807-3810.
42. Florio P., Rivest S., Reis F.M., Simoncini T., Martinelli P., Genazzani A.R., Petraglia F. Lack of gestational-related changes of urocortin gene expression in human placenta. Prenat. Neonat. Med. 1999, 4:296-300.
43. Petraglia F., Florio P., Gallo R., Salvestroni C., Lombardo M., Genazzani A.D., Di Carlo C., Stomati M., D'Ambrogio G., Artini P.G. Corticotropin-releasing factor-binding protein: origins and possible functions. Horm. Res. 1996, 45:187-191.
44. Petraglia F., Potter E., Cameron V.A., Sutton S., Behan D.P., Woods R.J., Sawchenko P.E., Lowry P.J., Vale W. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J. Clin. Endocrinol. Metab. 1993, 77:919-924.
45. Karteris E., Grammatopoulos D., Dai Y., Olah K.B., Ghobara T.B., Easton A., Hillhouse E.W. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1 alpha (CRH-1 alpha) and the CRH-C variant receptor. J. Clin. Endocrinol. Metab. 1998, 83:1376-1379.
46. Florio P., Franchini A., Reis F.M., Pezzani I., Ottaviani E., Petraglia F. Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. Placenta 2000, 21:32-37.
47. Hillhouse E.W., Grammatopoulos D.K. Role of stress peptides during human pregnancy and labour. Reproduction 2002, 124:323-329.
48. Florio P., Severi F.M., Ciarmela P., Fiore G., Calonaci G., Merola A., De Felice C., Palumbo M., Petraglia F. Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family. Endocrine 2002, 19:91-102.
49. Economides D., Linton E., Nicolaides K., Rodeck C.H., Lowry P.J., Chard T. Relationship between maternal and fetal corticotrophin-releasing hormone-41 and ACTH levels in human mid-trimester pregnancy. J. Endocrinol. 1987, 114:497-501.
50. Goland R.S., Wardlaw S.L., Blum M., Tropper P.J., Stark R.I. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am. J. Obstet. Gynecol. 1988, 159:884-890.
51. Laatikainen T.J., Raisanen I.J., Salminen K.R. Corticotropin-releasing hormone in amniotic fluid during gestation and labor and in relation to fetal lung maturation. Am. J. Obstet. Gynecol. 1988, 159:891-895.
52. Petraglia F., Giardino L., Coukos G., Calza L., Vale W., Genazzani A.R. Corticotropin-releasing factor and parturition: plasma and amniotic fluid levels and placental binding sites. Obstet. Gynecol. 1990, 75:784-790.
53. Korebrits C., Ramirez M.M., Watson L., Brinkman E., Bocking A.D., Challis J.R. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J. Clin. Endocrinol. Metab. 1998, 83:1585-1591.
54. Petraglia F., Florio P., Benedetto C., Gallo C., Woods R.J., Genazzani A.R., Lowry P.J. High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 1996, 81:852-856.
55. Laatikainen T., Virtanen T., Kaaja R., Salminen-Lappalainen K. Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 1991, 39:19-24.
56. Linton E.A., Perkins A.V., Woods R.J., Eben F., Wolfe C.D., Behan D.P., Potter E., Vale W.W., Lowry P.J. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 1993, 76:260-262.
57. Petraglia F., Florio P., Simoncini T., Woods R.J., Giuntini A., Gremigni R., Serra G.B., Genazzani A.R., Lowry P.J. Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour. Placenta 1997, 18:115-119.
58. Florio P., Woods R.J., Genazzani A.R., Lowry P.J., Petraglia F. Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor. J. Clin. Endocrinol. Metab. 1997, 82:835-838.
59. Berkowitz G.S., Lapinski R.H., Lockwood C.J., Florio P., Blackmore Prince C., Petraglia F. Corticotropin-releasing factor and its binding protein: maternal serum levels in term and preterm deliveries. Am. J. Obstet. Gynecol. 1996, 174:1477-1478.
60. Glynn B.P., Wolton A., Rodriguez-Linares B., Phaneuf S., Linton E.A. Urocortin in pregnancy. Am. J. Obstet. Gynecol. 1998, 179:533-539.
61. Florio P., Cobellis L., Woodman J., Severi F.M., Linton E.A., Petraglia F. Levels of maternal plasma corticotropin-releasing factor and urocortin during labor. J. Soc. Gynecol. Investig. 2002, 9:233-237.
62. Sassolas G. Growth hormone-releasing hormone: past and present. Horm. Res. 2000, 53:88-92.
63. Berry S.A., Srivastava C.H., Rubin L.R., Phipps W.R., Pescovitz O.H. Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta. J. Clin. Endocrinol. Metab. 1992, 75:281-284.
64. Mizobuchi M., Downs T.R., Frohman L.A. Growth hormone-releasing hormone immunoreactivity in mouse placenta, maternal blood, and amniotic fluid: molecular characterization and secretion from primary cell cultures in vitro. Endocrinology 1995, 136:1731-1736.
65. Margioris A.N., Brockmann G., Bohler H.C., Grino M., Vamvakopoulos N., Chrousos G.P. Expression and localization of growth hormone-releasing hormone messenger ribonucleic acid in rat placenta: in vitro secretion and regulation of its peptide product. Endocrinology 1990, 126:151-158.
66. Hofland L.J., Lamberts S.W. The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr. Rev. 2003, 24:28-47.
67. Kumasaka T., Nishi N., Yaoi Y., Kido Y., Saito M., Okayasu I., Shimizu K., Hatakeyama S., Sawano S., Kokubu K. Demonstration of immunoreactive somatostatin-like substance in villi and decidua in early pregnancy. Am. J. Obstet. Gynecol. 1979, 134:39-44.
68. Watkins W.B., Yen S.S. Somatostatin in cytotro-phoblast of the immature human placenta: localization by immunoperoxidase cytochemistry. J. Clin. Endocrinol. Metab. 1980, 50:969-971.
69. Saito H., Saito S., Sano T., Hosoi E., Saito H. Fetal and maternal plasma levels of immunoreactive somatostatin at delivery: evidence for its increase in the umbilical artery and its arterio-venous gradient in the feto-placental circulation. J. Clin. Endocrinol. Metab. 1983, 56:567-571.
70. Caron P., Buscail L., Beckers A., Esteve J.P., Igout A., Hennen G., Susini C. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J. Clin. Endocrinol. Metab. 1997, 82:3771-3776.
71. Strazzulla G., Guazzelli R., Romano S., Matassi L., Cotrozzi G., Brocchi A. Circadian variations of plasma somatostatin levels in healthy subjects. Chronobiologia 1990, 17:219-225.
72. Saito H., Saito S., Sano T., Hosoi E., Saito H. Fetal and maternal plasma levels of immunoreactive somatostatin at delivery: evidence for its increase in the umbilical artery and its arterio-venous gradient in the feto-placental circulation. J. Clin. Endocrinol. Metab. 1983, 56:567-571.
73. Sann L., Chayvialle J.A., Descos F. Plasma somatostatin concentration in the preterm neonate. Eur. J. Pediatr. 1982, 139:148-150.
74. Goldstein A., Armony-Sivan R., Rozin A., Weller A. Somatostatin levels during infancy, pregnancy, and lactation: a review. Peptides 1995, 16:1321-1326.
75. Birken S., Berger P., Bidart J.M., Weber M., Bristow A., Norman R., et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin. Chem. 2003, 49:144-154.
76. Eldar-Geva T., Hochberg A., deGroot N., Weinstein D. High maternal serum chorionic gonadotropin level in Downs' sindrome pregnancies is caused by elevation of both subunits messenger ribonucleic acid level in trophoblasts. J. Clin. Endocrinol. Metab. 1995, 80:3528-3531.
77. Reshef E., Lei Z.M., Rao C.V., Pridham D.D., Chegini N., Luborsky J.L. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J. Clin. Endocrinol. Metab. 1990, 70:421-430.
78. Davies S., Byrn F., Cole L.A. Human chorionic gonadotropin testing for early pregnancy viability and complications. Clin. Lab. Med. 2003, 23:257-264.
79. Cole L.A. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin. Chem. 1997, 43:2233-2243.
80. Cole L.A., Kardana A., Park S.-Y., Braunstein G.D. The deactivation of hCG by nicking and dissociation. J. Clin. Endocrinol. Metab. 1993, 76:704-713.
81. Birken S., Armstrong E.G., Kolks M.A., Cole L.A., Agosto G.M., Krichevsky A., et al. Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology 1988, 123:572-583.
82. O'Connor J.F., Schlatterer J.P., Birken S., Krichevsky A., Armstrong E.G., McMahon D., et al. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies. Cancer Res 1988, 48:1361-1366.
83. Soper J.T., Mutch D.G., Schink J.C., American College of Obstetricians and Gynecologists Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol. Oncol. 2004, 93:575-585.
84. Tay J.I., Moore J., Walker J.J. Ectopic pregnancy. BMJ 2000, 320:916-919.
85. Bogart M.H., Pandian M.R., Jones O.W. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat. Diagn. 1987, 7:623-630.
86. Kellner L.H., Weiner Z., Weiss R.R., Neuer M., Martin G.M., Mueenuddin M., Bombard A. Triple marker (α-fetoprotein, unconjugated estriol, human chorionic gonadotropin) vs. α-fetoprotein plus free-β subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Am. J. Obstet. Gynecol. 1995, 173:1306-1309.
87. Extermann P., Bischof P., Marguerat P., Mermillod B. Second trimester maternal serum screening for Down's syndrome: free β-human chorionic gonadotrophin (HCG) and α-fetoprotein, with or without unconjugated oestriol, compared with total HCG, α-fetoprotein and unconjugated oestriol. Hum. Reprod. 1998, 13:220-223.
88. Reis F.M., D'Antona D., Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr. Rev. 2002, 23:230-257.
89. Tegeder I., Geisslinger G. Opioids as modulators of cell death and survival: unraveling mechanisms and revealing new indications. Pharmacol. Rev. 2004, 56:351-369.
90. Agbas A., Ahmed M.S., Millington W., Cemerikic B., Desiderio D.M., Tseng J.L., Dass C. Dynorphin A(1-8) in human placenta: amino acid sequence determined by tandem mass spectrometry. Peptides 1995, 16:623-627.
91. Ahmed M.S., Cemerikic B., Agbas A. Properties and functions of human placental opioid system. Life Sci 1992, 50:83-97.
92. Odagiri E., Sherrell B.J., Mount C.D., Nicholson W.E., Orth D.N. Human placental immunoreactive corticotropin, lipotropin, and beta-endorphin: evidence for a common precursor. Proc. Natl. Acad. Sci. U S A 1979, 76:2027-2031.
93. Liotta A.S., Krieger D.T. In vitro biosynthesis and comparative posttranslational processing of immunoreactive precursor corticotropin/beta-endorphin by human placental and pituitary cells. Endocrinology 1980, 106:1504-1511.
94. Facchinetti F., Garuti G., Petraglia F., Mercantini F., Genazzani A.R. Changes in beta-endorphin in fetal membranes and placenta in normal and pathological pregnancies. Acta Obstet. Gynecol. Scand. 1990, 69:603-607.
95. Sastry B.V., Barnwell S.L., Tayeb O.S., Janson V.E., Owens L.K. Occurrence of methionine enkephalin in human placental villus. Biochem. Pharmacol. 1980, 29:475-478.
96. Porthe G., Valette A., Cros J. Kappa opiate binding sites in human placenta. Biochem. Biophys. Res. Commun. 1981, 101:1-6.
97. Porthe G., Valette A., Moisand A., Tafani M., Cros J. Localization of human placental opiate binding sites on the syncytial brush border membrane. Life Sci 1982, 31:2647-2654.
98. Cemerikic B., Schabbing R., Ahmed M.S. Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue. Peptides 1992, 13:897-903.
99. Genazzani A.R., Facchinetti F., Parrini D. Beta-lipotrophin and beta-endorphin plasma levels during pregnancy. Clin. Endocrinol. (Oxf) 1981, 14:409-418.
100. Newnham J.P., Tomlin S., Ratter S.J., Bourne G.L., Rees L.H. Endogenous opioid peptides in pregnancy. Br. J. Obstet. Gynaecol. 1983, 90:535-538.
101. Genazzani A.R., Petraglia F., Parrini D., Nasi A., Angioni G., Facchinetti F., Facchini V., Volpe A. Lack of correlation between amniotic fluid and maternal plasma contents of beta-endorphin, beta-lipotropin, and adrenocorticotropic hormone in normal and pathologic pregnancies. Am. J. Obstet. Gynecol. 1984, 148:198-203.
102. Mauri A., Serri F., Caminiti F., Mancuso S., Fratta W., Gessa G.L., Argiolas A. Correlation between amniotic levels of alpha-MSH, ACTH and beta-endorphin in late gestation and labour in normal and complicated pregnancies. Acta Endocrinol. (Copenh). 1990, 123:637-642.
103. Zanardo V., Nicolussi S., Carlo G., Marzari F., Faggian D., Favaro F., Plebani M. Beta endorphin concentrations in human milk. J. Pediatr. Gastroenterol. Nutr. 2001, 33:160-164.
104. Valette A., Desprat R., Cros J., Pontonnier G., Belisle S., Lemaire S. Immunoreactive dynorphine in maternal blood, umbilical vein and amniotic fluid. Neuropeptides 1986, 7:145-151.
105. Alsat E., Guibourdenche J., Couturier A., Evain Brion D. Physiological role of human placental growth hormone. Mol. Cell. Endocrinol. 1998, 140:121-127.
106. Scippo M.L., Frankenne F., Hooghe-Peters E.L., Igout A., Velkeniers B., Hennen G. Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol. Cell. Endocrinol. 1993, 92:R7-R13.
107. Frendo J.L., Therond P., Guibourdenche J., Bidart J.M., Vidaud M., Evain-Brion D. Modulation of copper/zinc superoxide dismutase expression and activity with in vitro differentiation of human villous cytotrophoblasts. Placenta 2000, 21:773-781.
108. Lytras A., Bock M.E., Dodd J.G., Cattini P.A. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction. Endocrinology 1994, 134:2461-2467.
109. Ray J., Okamura H., Kelly P.A., Liebhaber S.A., Cooke N.E. Alteration in the receptor binding specificity of human growth hormone by genomic exon exchange. Mol. Endocrinol. 1990, 4:101-107.
110. Baumann G., Davila N., Shaw M.A., Ray J., Liebhaber S.A., Cooke N.E. Binding of human growth hormone (GH)-variant (placental GH) to GH-binding proteins in human plasma. J. Clin. Endocrinol. Metab. 1991, 73:1175-1179.
111. Herington A.C., Ymer S.I., Stevenson J.L., Roupas P. Growth hormone receptor/binding protein: physiology and function. Proc. Soc. Exp. Biol. Med. 1994, 206:238-242.
112. Hill D.J., Riley S.C., Bassett N.S., Waters M.J. Localization of the growth hormone receptor, identified by immunocytochemistry, in second trimester human fetal tissues and in placenta throughout gestation. J. Clin. Endocrinol. Metab. 1992, 75:646-650.
113. McIntyre H.D., Serek R., Crane D.I., Veveris-Lowe T., Parry A., Johnson S., Leung K.C., Ho K.K., Bougoussa M., Hennen G., Igout A., Chan F.Y., Cowley D., Cotterill A., Barnard R. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J. Clin. Endocrinol. Metab. 2000, 85:1143-1150.
114. Frankenne F., Closset J., Gomez F., Scippo M.L., Smal J., Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J. Clin. Endocrinol. Metab. 1988, 66:1171-1180.
115. Mirlesse V., Frankenne F., Alsat E., Poncelet M., Hennen G., Evain-Brion D. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr. Res. 1993, 34:439-442.
116. Eriksson L. Growth hormone in human pregnancy. Maternal 24-hour serum profiles and experimental effects of continuous GH secretion. Acta Obstet. Gynecol. Scand. 1989, 147:1-38.
117. Evain-Brion D., Alsat E., Igout A., Frankenne F., Hennen G. Placental growth hormone variant: assay and clinical aspects. Acta Paediatr. Suppl. 1994, 399:49-51.
118. Barnard R., Chan F.Y., McIntyre H.D. Growth hormone-binding protein in normal and pathologic gestation: correlations with maternal diabetes and fetal growth. J. Clin. Endocrinol. Metab. 1997, 82:1879-1884.
119. Josimovich J.B., MacLaren J.A. Presence in human placenta and term serum of highly lactogenic substance immunologically related to pituitary growth hormone. Endocrinology 1962, 71:209-215.
120. Jaffe R.B. Neuroendocrine-metabolic regulation of pregnancy. Reproductive Endocrinology 1998, 751-784. WB Saunders, New York. S.S.C. Yen, R.B. Jaffe, R.L. Barbieri (Eds.).
121. Walker W.H., Fitzpatrick S.L., Barrera-Saldana H.A., Resendez-Perez D., Saunders G.F. The human placental lactogen genes: structure, function, evolution and transcriptional regulation. Endocr. Rev. 1991, 12:316-328.
122. Handwerger S., Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J. Pediatr. Endocrinol. Metab. 2000, 13:343-356.
123. Jacobsen G., Hoffman H.J., Bakketeig L.S. Small-for-gestational-age (SGA) infants born at term: growth and development during the first year of life. Acta Obstet. Gynecol. Scand. 1997, 165:93-101.
124. Pedrazzini T., Pralong F., Grouzmann E. Neuropeptide Y: the universal soldier. Cell. Mol. Life Sci. 2003, 60:350-377.
125. Petraglia F., Calzà L., Giardino L., Sutton S., Marrama P., Rivier J., Genazzani A.R., Vale W. Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites. Endocrinology 1989, 124:2016-2022.
126. Petraglia F., Calzà L., Giardino L., Zanni M., Florio P., Ferrari A.R., Nappi C., Genazzani A.R. Maternal decidua and fetal membranes contain immunoreactive neuropeptide Y. J. Endocrinol. Invest. 1993, 16:201-205.
127. Robidoux J., Simoneau L., St-Pierre S., Ech-Chadli H., Lafond J. Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis. Am. J. Physiol. 1998, 274:E502-E509.
128. Wharton J., Gordon L., Byrne J., Herzog H., Selbie L.A., Moore K., Sullivan M.H., Elder M.G., Moscoso G., Taylor K.M., Shine J., Polak J.M. Expression of the human neuropeptide tyrosine Y1 receptor. Proc. Natl. Acad. Sci. U S A 1993, 90:687-691.
129. Cikos S., Gregor P., Koppel J. Sequence and tissue distribution of a novel G-protein-coupled receptor expressed prominently in human placenta. Biochem. Biophys. Res. Commun. 1999, 256:352-356.
130. Petraglia F., Coukos G., Battaglia C., Bartolotti A., Volpe A., Nappi C., Segre A., Genazzani A.R. Plasma and amniotic fluid immunoreactive neuropeptide-Y level changes during pregnancy, labor, and at parturition. J. Clin. Endocrinol. Metab. 1989, 69:324-328.
131. Khatun S., Kanayama N., Belayet H.M., Bhuiyan A.B., Jahan S., Begum A., Kobayashi T., Terao T. Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia. Am. J. Obstet. Gynecol. 2000, 182:896-900.
132. Taupenot L., Harper K.L., O'Connor D.T. The chromogranin-secretogranin family. N. Engl. J. Med. 2003, 348:1134-1149.
133. Syversen U., Waldum H.L., O'Connor D.T. Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas. Nueropeptides 1992, 22:235-240.
134. Moftaquir-Handaj A., Barbe F., Barbarino-Monnier P., Aunis D., Boutroy M.J. Circulating chromogranin A and catecholamines in human fetuses at uneventful birth. Pediatr. Res. 1995, 37:101-105.
135. Florio P., Mezzesimi A., Turchetti V., Severi F.M., Ticconi C., Forconi S., Petraglia F. High levels of human chromogranin A in umbilical cord plasma and amniotic fluid at parturition. J. Soc. Gynecol. Investig. 2002, 9:32-36.
136. Brownstein M.J., Russell J.T., Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 1980, 207:373-378.
137. Mitchell B. Oxytocin synthesis and metabolism in human decidua. Reprod. Fertil. Dev. 1995, 7:319-321.
138. Chibbar R., Miller F.D., Mitchell B.F. Local synthesis of oxytocin in amnion, chorion and decidua may regulate the timing of parturition. J. Clin. Invest. 1993, 91:185-192.
139. Blanks A.M., Thornton S. The role of oxytocin in parturition. BJOG 2003, 110:46-51.
140. Mauri A., Argiolas A., Ticconi C., Piccione E. Oxytocin in human intrauterine tissues at parturition. Reprod. Fertil. Dev. 1995, 7:1481-1484.
141. Zingg H.H., Laporte S.A. The oxytocin receptor. Trends Endocrinol. Metab. 2003, 14:222-227.
142. Zeeman G.G., Khan-Dawood F.S., Dawood M.Y. Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications. Obstet. Gynecol. 1997, 89:873-883.
143. Wathes D.C., Borowick S.C., Timmons P.M., Leung S.T., Thornton S. Oxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labour. J. Endocrinol. 1999, 161:134-151.
144. Birnbaumer M. Vasopressin receptors. Trends Endocrinol. Metab. 2000, 11:406-410.
145. Ivanisevic M., Behrens O., Helmer H., Demarest K., Fuchs A.-R. Vasopressin receptors in human pregnant myometrium and decidua: interactions with oxytocin and vasopressin agonists and antagonists. Am. J. Obstet. Gynecol. 1989, 161:1637-1643.
146. Fuchs A.-R., Romero R., Keefe D., Parra M., Oyarzun E., Behnke E. Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am. J. Obstet. Gynecol. 1991, 165:1515-1523.
147. Otsuki Y., Yamaji K., Fujita M. Serial plasma oxytocin concentrations during pregnancy and labor. Acta Obstet. Gynecol. Scand. 1983, 62:15-18.
148. Chard T., Hudson C.N., Edwards C.R.W., Boyd N.R.H. Release of oxytocin and vasopressin by the human foetus during labour. Nature 1971, 234:352-353.
149. Thornton S., Baldwin P.J., Harris P.A., Harding F., Davison J.M., Baylis P.H., Timmons P.M., Wathes D.C. The role of arginine vasopressin in human labour: functional studies, fetal production and localisation of V1a receptor mRNA. Br. J. Obstet. Gynaecol. 2002, 109:57-62.
150. Nussdorfer G.G., Malendowicz L.K. Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 1998, 19:949-968.
151. Page N.M., Woods R.J., Gardiner S.M., Lomthaisong K., Gladwell R.T., Butlin D.J., Manyonda I.T., Lowry P.J. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 2000, 405:797-800.
152. Brownbill P., Bell N.J., Woods R.J., Lowry P.J., Page N.M., Sibley C.P. Neurokinin B is a paracrine vasodilator in the human fetal placental circulation. J. Clin. Endocrinol. Metab. 2003, 88:2164-2170.
153. Patak E., Candenas M.L., Pennefather J.N., Ziccone S., Lilley A., Martin J.D., Flores C., Mantecon A.G., Story M.E., Pinto F.M. Tachykinins and tachykinin receptors in human uterus. Br. J. Pharmacol. 2003, 139:523-532.
154. Sakamoto R., Osada H., Iitsuka Y., Masuda K., Kaku K., Seki K., Sekiya S. Profile of neurokinin B concentrations in maternal and cord blood in normal pregnancy. Clin. Endocrinol. (Oxf). 2003, 58:597-600.
155. Nguyen T.T., Tseng Y.T., McGonnigal B., Stabila J.P., Worrell L.A., Saha S., Padbury J.F. Placental biogenic amine transporters: in vivo function, regulation and pathobiological significance. Placenta 1999, 20:3-11.
156. Manyonda I.T., Slater D.M., Fenske C., Hole D., Choy M.Y., Wilson C. A role for noradrenaline in pre-eclampsia, towards a unifying hypothesis for the pathophysiology. Br. J. Obstet. Gynaecol. 1998, 105:641-648.
157. Bzoskie L., Yen J., Tseng Y.T., Blount L., Kashiwai K., Padbury J.F. Human placental norepinephrine transporter mRNA: expression and correlation with fetal condition at birth. Placenta 1997, 18:205-210.
158. Kenney S.P., Kekuda R., Prasad P.D., Leibach F.H., Devoe L.D., Ganapathy V. Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am. J. Obstet. Gynecol. 1999, 181:491-497.
159. Chang H., Brown C.W., Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 2002, 23:787-823.
160. Ando N., Hirahara F., Fukushima J., Kawamoto S., Okuda K., Funabashi T.,
161. Kauma S., Matt D., Strom S., Eierman D., Turner T. Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes. Am. J. Obstet. Gynecol. 1990, 163:1430-1437.
162. Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., Lye S.J. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J. Clin. Invest. 1999, 103:1641-1650.
163. Selick C., Horowitz G., Gratch M., Scott R., Navot D., Hofmann G. Immunohistochemical localization of transforming growth factorbeta in human implantation sites. J. Clin. Endocrinol. Metab. 1994, 78:592-596.
164. Dungy L.J., Siddiqi T.A., Khan S. Transforming growth factor-beta1 expression during placental development. Am. J. Obstet. Gynecol. 1991, 165:853-857.
165. Caniggia I., Mostachfi H., Winter J., Gassmann M., Lye S.J., Kuliszewski M., Post M. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J. Clin. Invest. 2000, 105:577-587.
166. Cheifetz S., Bellon T., Cales C., Vera S., Bernabeu C., Massague J., Letarte M. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem. 1992, 267:19027-19030.
167. Schilling B., Yeh J. Transforming growth factorbeta(1),-beta(2),-beta(3) and their type I and II receptors in human term placenta. Gynecol. Obstet. Invest. 2000, 50:19-23.
168. St-Jacques S., Forte M., Lye S.J., Letarte M. Localization of endoglin, a transforming growth-factor-β binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol. Reprod. 1994, 51:405-413.
169. Gougos A., St-Jacques S., Greaves A., O'Connell P.J., d'Apice A.J., Buhring H.J., Bernabeu C., Van Hourik J.A., Letarte M. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int. Immunol. 1992, 4:83-92.
170. Hennessy A., Orange S., Willis N., Painter D.M., Child A., Horvath J.S. Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia. Clin. Exp. Pharmacol. Physiol. 2002, 29:968-971.
171. Caniggia I., Winter J.L. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies-a review. Placenta 2002, 23:S47-S57.
172. Petraglia F., Sawchenko P., Lim A.T., Rivier J., Vale W. Localization, secretion, and action of inhibin in human placenta. Science 1987, 237:187-189.
173. Petraglia F., Calza L., Garuti G.C., Abrate M., Giardino L., Genazzani A.R., Vale W., Meunier H. Presence and synthesis of inhibin subunits in human decidua. J. Clin. Endocrinol. Metab. 1990, 71:487-492.
174. Petraglia F., Anceschi M.M., Calza L., Garuti G.C., Fusaro P., Giardino L., Genazzani A.R., Vale W. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J. Clin. Endocrinol. Metab. 1993, 77:542-548.
175. Schneider-Kolsky M.E., Manuelpillai U., Waldron K., Dole A., Wallace E.M. The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour. Placenta 2002, 23:294-302.
176. Silver H.M., Lambert-Messerlian G.M., Reis F.M., Diblasio A.M., Petraglia F., Canick J.A. Mechanism of increased maternal serum total activin A and inhibin A in preeclampsia. J. Soc. Gynecol. Investig. 2002, 9:308-312.
177. Hayette S., Gadoux M., Martel S., Bertrand S., Tigaud I., Magaud J.P., Rimokh R. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 1998, 16:2949-2954.
178. Ciarmela P., Florio P., Toti P., Franchini A., Maguer-Satta V., Ginanneschi C., Ottaviani E., Petraglia F. Human placenta and fetal membranes express follistatin-related gene mRNA and protein. J. Endocrinol. Invest. 2003, 26:641-645.
179. Petraglia F., Gallinelli A., Grande A., Florio P., Ferrari S., Genazzani A.R., Ling N., DePaolo L.V. Local production and action of follistatin in human placenta. J. Clin. Endocrinol. Metab. 1994, 78:205-210.
180. Kozian D.H., Ziche M., Augustin H.G. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab. Invest. 1997, 76:267-276.
181. Gray P.C., Bilezikjian L.M., Vale W. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Mol. Cell. Endocrinol. 2002, 188:254-260.
182. Ciarmela P., Florio P., Toti P., Grasso D., Santopietro R., Tosi P., Petraglia F. Expression of betaglycan in pregnant tissues throughout gestation. Eur. J. Endocrinol. 2003, 149:433-437.
183. Florio P., Cobellis L., Luisi S., Ciarmela P., Severi F.M., Bocchi C., Petraglia F. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol. Cell. Endocrinol. 2001, 180:123-130.
184. Florio P., Luisi S., Ciarmela P., Severi F.M., Bocchi C., Petraglia F. Inhibins and activins in pregnancy. Mol. Cell. Endocrinol. 2004, 225:93-100.
185. Luisi S., Florio P., D'Antona D., Severi F.M., Sanseverino F., Danero S., Petraglia F. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. Eur. J. Endocrinol. 2003, 148:233-236.
186. Florio P., Luisi S., D'Antona D., Severi F.M., Rago G., Petraglia F. Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertil. Steril. 2004, 81:468-470.
187. Wallace E.M., Schneider-Kolsky M.E., Edwards A., Baker L., Jenkin G. Maternal serum activin A levels in association with intrauterine fetal growth restriction. BJOG 2003, 110:306-310.
188. Le Roith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 2001, 22:53-74.
189. Graham C.H., Lysiak J.J., McCrae K.R., Lala P.K. Localization of insulin-like growth factor I mRNA in the developing human placenta and in term placenta of diabetics. Mol. Endocrinol. 1992, 2:217-221.
190. Zhou J., Bondy C. Insulin-like growth factor II and its binding proteins in placental development. Endocrinology 1992, 131:1230-1240.
191. Nayak N.R., Giudice L.C. Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 2003, 24:281-296.
192. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 2002, 23:8248-8254.
193. Hill D.J., Clemmons D.R., Riley S.C., Bassett N., Challis J.R.G. Immunohistochemical localization of insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, -3 in human placenta and fetal membranes. Placenta 1993, 14:1-12.
194. Wathen N.C., Wang H.S., Cass P.L., Campbell D.J., Chard T. Insulin-like growth factor-1 and insulin-like growth factor binding protein-1 in early human pregnancy. Early Hum. Dev. 1991, 28:105-110.
195. Han V.K., Bassett N., Walton J., Challis J.R. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the fetomaternal interface. J. Clin. Endocrinol. Metab. 1996, 81:2680-2693.
196. Fant M. Insulin-like growth factor binding proteins (BP) from human placenta are immunologically related to growth hormone dependent binding protein in adult human serum (BP-53). Placenta 1990, 11:123-133.
197. Davenport M.L., Clemmons D.R., Miles M.V., Camacho-Hubner C., D'Ercole A.J., Underwood L.E. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein during rat pregnancy. Endocrinology 1990, 127:1278-1286.
198. Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr. Res. 1991, 29:219-225.
199. Giudice L.C., Farell E.M., Pham H., Lamson G., Rosenfeld R.G. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J. Clin. Endocrinol. Metab. 1990, 71:806-810.
200. Shimasaki S., Uchiyama F., Shimonaka M., Ling N. Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol. Endocrinol. 1990, 4:1451-1458.
201. Sun I.Y., Overgaard M.T., Oxvig C., Giudice L.C. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane. J. Clin. Endocrinol. Metab. 2002, 87:5235-5240.
202. Bonno M., Oxvig C., Kephart G.M., Wagner J.M., Kristensen T., Sottrup-Jensen L., Gleich G.J. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab. Invest. 1994, 71:560-566.
203. Hall K., Enberg G., Hellem E., Lundin G., Ottosson-Seeberger A., Sara V., Trygstad O., Ofverholm U. Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 1984, 59:587-594.
204. Monaghan J.M., Godber I.M., Lawson N., Kaur M., Wark G., Teale D., Hosking D.J. Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy. Ann. Clin. Biochem. 2004, 41:220-226.
205. Ingec M., Gursoy H.G., Yildiz L., Kumtepe Y., Kadanali S. Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int. J. Gynaecol. Obstet. 2004, 84:214-219.
206. Monzavi R., Cohen P. IGFs and IGFBPs: role in health and disease. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16:433-447.
207. Holmes R., Montemagno R., Jones J., Preece M., Rodeck C., Soothill P. Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth. Early Hum. Dev. 1997, 49:7-17.
208. Folkersen J., Grudzinskas J.G., Hindersson P., Teisner B., Westergaard J.G. Pregnancy-associated plasma protein A: circulating levels during normal pregnancy. Am. J. Obstet. Gynecol. 1981, 139:910-914.
209. Canick J.A., Kellner L.H. First trimester screening for aneuploidy: serum biochemical markers. Semin. Perinatol. 1999, 5:359-368.
210. Knight G.J., Palomaki G.E., Haddow J.E., Miller W., Bersinger N.A., Schneider H. Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancy. Prenat. Diagn. 1993, 13:222-223.
211. Reuss B., von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 2003, 313:139-157.
212. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 2003, 284:31-53.
213. Gospodarowicz D., Cheng J., Lui G.M., Fujii D.K., Baird A., Bohle N.P. Fibroblast growth factor in the human placenta. Biochem. Biophys. Res. Commun. 1985, 128:554-562.
214. Di Blasio A.M., Carniti C., Vigano P., Florio P., Petraglia F., Vignali M. Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal and pathological pregnancies. Mol. Hum. Reprod. 1997, 3:1119-1123.
215. Cattini P.A., Nickel B., Bock M., Kardami E. Immunolocalization of basic fibroblast growth factor (bFGF) in growing and growth-inhibited placental cells: a possible role for bFGF in placental cell development. Placenta 1993, 12:341-352.
216. Hofmann G.E., Scott R.T., Bergh P.A., Deligdisch L. Immunohistochemical localization of epidermal growth factor in human endometrium, decidua, and placenta. J. Clin. Endocrinol. Metab. 1991, 73:882-886.
217. Eaton B.M., Richards R.C., Contractor S.F. Uptake and metabolism of epidermal growth factor in the perifused human placenta. J. Dev. Physiol. 1987, 9:69-78.
218. Maruo T., Matsuo H., Otani T., Mochizuki M. Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta. Reprod. Fertil. Dev. 1995, 7:1465-1470.
219. Hofmann G.E., Abramowicz J.S. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet. Gynecol. (Scand). 1990, 69:217-220.
220. Cross M.J., Dixelius J., Matsumoto T., Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem. Sci. 2003, 28:488-494.
221. Autiero M., Luttun A., Tjwa M., Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J. Thromb. Haemost. 2003, 1:1356-1370.
222. Vuorela P., Hatva E., Lymboussaki A., Kaipainen A., Joukov V., Persico M.G., Alitalo K., Halmesmaki E. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol. Reprod. 1997, 56:489-494.
223. Shiraishi S., Nakagawa K., Kinukawa N., Nakano H., Sueishi K. Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996, 17:111-121.
224. Shore V.H., Wang T.H., Wang C.L., Torry R.J., Caudle M.R., Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997, 18:657-665.
225. Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., Alitalo K., Damsky C., Fisher S.J. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 2002, 160:1405-1423.
226. Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J., Weich H., Ahmed A. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 1996, 13:243-250.
227. Nagamatsu T., Fujii T., Kusumi M., Li Z., Yamashita T., Osuga Y., Momoeda M., Kozuma S., Taketani Y. Cytotrophoblasts up-regulate soluble Fms-like tyrosine Kinase-1 (sFlt-1) expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004, 145:4838-4845.
228. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255:989-991.
229. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 1992, 187:1579-1586.
230. Park J.E., Chen H.H., Winer J., Houck K.A., Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 1994, 269:25646-25654.
231. Crescimanno C., Foidart J.M., Noel A., Polette M., Maquoi E., Birembaut P., Baramova E., Kaufmann P., Castellucci M. Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A. Exp. Cell Res. 1996, 227:240-251.
232. Charnock-Jones D.S., Sharkey A.M., Boocock C.A., Ahmed A., Plevin R., Ferrara N., Smith S.K. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod. 1994, 51:524-530.
233. Ahmed A., Li X.F., Dunk C., Whittle M.J., Rushton D.I., Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 1995, 12:235-243.
234. Kumazaki K., Nakayama M., Suehara N., Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum. Pathol. 2002, 33:1069-1077.
235. Soker S., Gollamudi-Payne S., Fidder H., Charmahelli H., Klagsbrun M. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J. Biol. Chem. 1997, 272:31582-31588.
236. Migdal M., Huppertz B., Tessler S., Comforti A., Shibuya M., Reich R., Baumann H., Neufeld G. Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem. 1998, 273:22272-22278.
237. Pajusola K., Aprelikova O., Korhonen J., Kaipainen A., Pertovaara L., Alitalo R., Alitalo K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 1992, 52:5738-5743.
238. Lee J., Gray A., Yuan J., Luoh S.M., Avraham H., Wood W.I. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. U S A 1996, 93:1988-1992.
239. Tsoi S.C., Wen Y., Chung J.Y., Chen D., Magness R.R., Zheng J. Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells. Mol. Cell. Endocrinol. 2002, 196:95-106.
240. Helske S., Vuorela P., Carpen O., Hornig C., Weich H., Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol. Hum. Reprod. 2001, 7:205-210.
241. Chung J.Y., Song Y., Wang Y., Magness R.R., Zheng J. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 2004, 89:2484-2490.
242. VanWijk M.J., Kublickiene K., Boer K., VanBavel E. Vascular function in preeclampsia. Cardiovasc. Res. 2000, 47:38-48.
243. Strauss J.F., Martinez F., Kiriakidou M. Placental steroid hormone synthesis: unique features and unanswered questions. Biol. Reprod. 1996, 54:303-311.
244. Aspillaga M.O., Whittaker P.G., Grey C.E., Lind T. Endocrinologic events in early pregnancy failure. Am. J. Obstet. Gynecol. 1983, 147:903-908.
245. Yen S.C., Jaffe R.B., Barbieri R.L. Endocrinology of pregnancy. Reproductive Endocrinology 1998, WB Saunders, Philadelphia. S.S.C. Yen, R.B. Jaffe, R.L. Barbieri (Eds.).
246. Pepe G., Rothchild I. The effect of hypophysectomy on day 12 of pregnancy on the serum progesterone level and time of parturition in the rat. Endocrinology 1972, 91:1380-1385.
247. Challis J.R.G., Matthews S.G., Gibb W., Lye S.J. Endocrine and paracrine regulation of birth at term and preterm. Endocr. Rev. 2000, 21:514-550.
248. Siiteri P.K., MacDonald P.C. Placental estrogen biosynthesis during human pregnancy. J. Clin. Endocrinol. Metab. 1966, 26:751-761.
249. Smith R., Mesiano S., McGrath S. Hormone trajectories leading to human birth. Regul. Pept. 2002, 108:159-164.
250. Kashork C.D., Sutton V.R., Fonda Allen J.S., Schmidt D.E., Likhite M.L., Potocki L., O'Brien W.E., Shaffer L.G. Low or absent unconjugated estriol in pregnancy: an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis. Prenat. Diagn. 2002, 22:1028-1032.
251. Korte K., Hemsell P.G., Mason J.I. Sterol sulfate metabolism in the adrenals of the human fetus, anencephalic newborn, and adult. J. Clin. Endocrinol. Metab. 1982, 55:671-675.
252. Newby D., Aitken D.A., Howatson A.G., Connor J.M. Placental synthesis of oestriol in Down's syndrome pregnancies. Placenta 2000, 21:263-267.
253. Cuckle H.S., Wald N.J., Barkai G., Fuhrmann W., Altland K., Brambati B., Knight G., Palomaki G., Haddow J.E., Canick J. First-trimester biochemical screening for Down syndrome. Lancet 1988, 2:851-852.
254. Ellis M.J., Livesey J.H., Inder W.J., Prickett T.C., Reid R. Plasma corticotropin-releasing hormone and unconjugated estriol in human pregnancy: gestational patterns and ability to predict preterm delivery. Am. J. Obstet. Gynecol. 2002, 186:94-99.
255. Heine R.P., McGregor J.A., Goodwin T.M., Artal R., Hayashi R.H., Robertson P.A., Varner M.W. Serial salivary estriol to detect an increased risk of preterm birth. Obstet. Gynecol. 2000, 96:490-497.
256. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 1993, 192:553-560.
257. Gratton R.J., Gluszynski M., Mazzuca D.M., Nygard K., Han V.K. Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 2003, 88:6048-6055.
258. Marinoni E., Di Iorio R., Letizia C., Villaccio B., Scucchi L., Cosmi E.V. Immunoreactive adrenomedullin in human fetoplacental tissues. Am. J. Obstet. Gynecol. 1998, 179:784-787.
259. Moriyama T., Otani T., Maruo T. Expression of adrenomedullin by human placental cytotrophoblasts and choriocarcinoma JAr cells. J. Clin. Endocrinol. Metab. 2001, 86:3958-3961.
260. Kanenishi K., Kuwabara H., Ueno M., Sakamoto H., Hata T. Immunohistochemical adrenomedullin expression is decreased in the placenta from pregnancies with pre-eclampsia. Pathol. Int. 2000, 50:536-540.
261. Marinoni E., Di Iorio R., Lucchini C., Di Netta T., Letizia C., Cosmi E.V. Adrenomedullin and nitric oxide synthase at the maternal-decidual interface in early spontaneous abortion. J. Reprod. Med. 2004, 49:153-161.
262. Di Iorio R., Marinoni E., Letizia C., Alò P., Villaccio B., Cosmi E.V. Adrenomedullin, a new vasoactive peptide, is increased in preeclampsia. Hypertension 1998, 32:758-763.
263. Knerr I., Dachert C., Beinder E., Metzler M., Dotsch J., Repp R., et al. Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclapsia and HELLP syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2002, 101:47-53.
264. Makino Y., Shibata K., Makino I., Ono Y., Kangawa K., Kawarabayashi T. Expression of adrenomedullin in feto-placental circulation of human normotensive pregnant women and pregnancy-induced hypertensive women. Endocrinology 1999, 140:5439-5442.
265. Trollmann R., Schoof E., Beinder E., Wenzel D., Rascher W., Dotsch J. Adrenomedullin gene expression in human placental tissue and leukocytes: a potential marker of severe tissue hypoxia in neonates with birth asphyxia. Eur. J. Endocrinol. 2002, 147:711-716.
266. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339.
267. Makino Y., Shibata K., Makino I., Kangawa K., Kawarabayashi T. Alteration of the adrenomedullin receptor components gene expression associated with the blood pressure in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 2001, 86:5079-5082.
268. Di Iorio R., Marinoni E., Letizia C., Villaccio B., Alberini A., Cosmi E.V. Adrenomedullin production is increased in normal human pregnancy. Eur. J. Endocrinol. 1999, 140:201-206.
269. Di Iorio R., Marinoni E., Cosmi E.V. New peptides, hormones and parturition. Gynecol. Endocrinol. 1998, 12:429-434.
270. Di Iorio R., Marinoni E., Letizia C., Alo P., Villaccio B., Poverini R., Cosmi E.V. Influence of labor on fetoplacental adrenomedullin concentrations. Am. J. Obstet. Gynecol. 2001, 185:697-702.
271. Di Iorio R., Marinoni E., Letizia C., Gazzolo D., Lucchini C., Cosmi E.V. Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms. Am. J. Obstet. Gynecol. 2000, 182:650-654.
272. Di Iorio R., Marinoni E., Letizia C., Cosmi E.V. Adrenomedullin in perinatal medicine. Regul. Pept. 2003, 112:103-113.
273. Pollock D.M., Keith T.L., Highsmith R.F. Endothelin receptors and calcium signaling. FASEB J. 1995, 9:1196-1204.
274. McMahon L.P., Redman C.W.G., Firth J.D. Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clin. Sci. 1993, 85:417-424.
275. Robert B., Malassine A., Bourgeois C., Mignot T.M., Cronier L., Ferre F., et al. Expression of endothelin precursor genes in human trophoblast in culture. Eur. J. Endocrinol. 1996, 134:490-496.
276. Marinoni E., Picca A., Scucchi L., Cosmi E.V., Di Iorio R. Immunohistochemical localization of endothelin-1 in placenta and fetal membranes in term and preterm human pregnancy. Am. J. Reprod. Immunol. 1995, 34:213-218.
277. Hemsen A., Gillis C., Larsson O., Haegerstrand A., Lundberg J.M. Characterization, localization and actions of endothelins in umbilical vessels and placenta of man. Acta Physiol. Scand. 1991, 143:395-404.
278. Napolitano M., Miceli F., Calce A., Vacca A., Gulino A., Apa R., Lanzone A. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J. Clin. Endocrinol. Metab. 2000, 85:2318-2323.
279. Matsumura Y., Ikegawa R., Tsukhara Y., Takaoka M., Morimoto S. Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett. 1990, 272:166-170.
280. Schmidt M., Kroger B., Jacob E., Seulberger H., Subkowski T., Otter R., Meyer T., Schmalzing G., Hillen H. Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 1994, 356:238-243.
281. Ahmad Z., Reznik S.E. Immunohistochemical localization of ECE-1 in the human placenta. Placenta 2000, 21:226-233.
282. Robert B., Malassiné A., Bourgeois C., et al. Expression of endothelin precursor genes in human trophoblast in culture. Eur. J. Endocrinol. 1996, 134:490-496.
283. Benigni A., Gaspari F., Orisio S., et al. Human placenta expresses endothelin gene and corresponding protein is excreted in increasing amounts during normal pregnancy. Am. J. Obstet. Gynecol. 1991, 164:844-848.
284. Smith P.L., Lee C.P., Pullen M., Ohlstein E.H., Beck G., Eddy E.P., et al. Non peptide endothelin receptor antagonists. IV. Identification of receptors in rabbit colonic muscosa and smooth muscle and correlation with physiological effects. J. Pharmacol. Exp. Ther. 1995, 272:1204-1210.
285. Rutherford R.A.D., Wharton J., McCarthy A., Gordon L., Sullivan M.H.F., Elder M.G., et al. Differential localization of endothelin ETA and ETB binding sites in human placenta. Br. J. Pharmacol. 1993, 109:544-552.
286. Hemsen A., Gillis C., Larsson O., Haegerstrand A., Lundberg J.M. Characterization, localization and actions of endothelins in umbilical vessels and placenta of man. Acta Physiol. Scand. 1991, 143:395-404.
287. Kohnen G., Mackenzie F., Collett G.P., Campbell S., Davenport A.P., Cameron I.T., et al. Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies. Placenta 1997, 18:173-180.
288. Nova A., Sibai B.M., Barton J.R., Mercer B.M., Mitchell M.D. Maternal plasma level of endothelin is increased in preeclampsia. Am. J. Obstet. Gynecol. 1991, 165:724-727.
289. Schiff E., Ben Baruch G., Peleg E., Rosenthal T., Alcalay M., Devir M., Mashiach S. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am. J. Obstet. Gynecol. 1992, 166:624-628.
290. Erdem A., Erdem M., Himmetoglu O., Yildirim G., Arslan M. Maternal and fetal plasma endothelin levels in intrauterine growth restriction: relation to umbilical artery Doppler flow velocimetry. J. Perinat. Med. 2003, 31:52-59.
291. Di Iorio R., Marinoni E., Anceschi M.M., Emiliani S., Letizia C., Cosmi E.V. Amniotic fluid endothelin-1 levels are increased in pregnancy-induced hypertension and intrauterine growth retardation. Am. J. Reprod. Immunol. 1996, 36:260-263.
292. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., Muff R., Fischer J.A., Foord S.M. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 2002, 54:233-246.
293. Tsatsaris V., Tarrade A., Merviel P., Garel J.M., Segond N., Jullienne A., Evain-Brion D. Calcitonin generelated peptide (CGRP) and CGRP receptor expression at the human implantation site. J. Clin. Endocrinol. Metab. 2002, 87:4383-4390.
294. Lafond J., St-Pierre S., Masse A., Savard R., Simoneau L. Calcitonin gene-related peptide receptor in human placental syncytiotrophoblast brush-border and basal plasma membranes. Placenta 1997, 18:181-188.
295. Dong Y.L., Fang L., Kondapaka S., Gangula P.R., Wimalawansa S.J., Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J. Clin. Invest. 1999, 104:559-565.
296. Chan K.K., Robinson G., Pipkin F.B. Differential sensitivity of human nonpregnant and pregnant myometrium to calcitonin gene-related peptide. J. Soc. Gynecol. Investig. 1997, 4:15-21.
297. Yallampalli C., Chauhan M., Thota C.S., Kondapaka S., Wimalawansa S.J. Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol. Metab. 2002, 13:263-269.
298. Florio P., Margutti A., Apa R., Miceli F., Pezzani I., Degli Uberti E.C., Petraglia F. Maternal plasma calcitonin gene-related peptide levels do not change during labour and are not influenced by delivery route. J. Soc. Gynecol. Investig. 2001, 8:165-168.
299. Schiff E., Friedman S.A., Sibai B.M., Kao L., Schifter S. Plasma and placental calcitonin gene-related peptide in pregnancies complicated by severe preeclampsia. Am. J. Obstet. Gynecol. 1995, 173:1405-1409.
300. Halhali A., Wimalawansa S.J., Berentsen V., Avila E., Thota C.S., Larrea F. Calcitonin gene- and parathyroid hormone-related peptides in preeclampsia: effects of magnesium sulfate. Obstet. Gynecol. 2001, 97:893-897.
301. Strewler G.J. The parathyroid hormone-related protein. Endocrinol. Metab. Clin. North Am. 2000, 29:629-645.
302. Ardawi M.S., Nasrat H.A., BA'Aqueel H.S. Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur. J. Endocrinol. 1997, 137:402-409.
303. Emly J.F., Gregory J., Bowden S.J., Ahmed A., Whittle M.J., Rushton D.I., Ratcliffe W.A. Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) in human term placenta and membranes. Placenta 1994, 15:653-660.
304. Curtis N.E., Ho P.W., King R.G., Farrugia W., Moses E.K., Gillespie M.T., Moseley J.M., Rice G.E., Wlodek M.E. The expression of parathyroid hormone-related protein mRNA and immunoreactive protein in human amnion and choriodecidua is increased at term compared with preterm gestation. J. Endocrinol. 1997, 154:103-112.
305. Clemens T.L., Cormier S., Eichinger A., Endlich K., Fiaschi-Taesch N., Fischer E., Friedman P.A., Karaplis A.C., Massfelder T., Rossert J., Schluter K.D., Silve C., Stewart A.F., Takane K., Helwig J.J. Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br. J. Pharmacol. 2001, 134:1113-1136.
306. Ferguson J.E., Gorman J.V., Bruns D.E., Weir E.C., Burtis W.J., Martin T.J., Bruns M.E. Abundant expression of parathyroid hormone-related protein in human amnion and its association with labor. Proc. Natl. Acad. Sci. U S A 1992, 89:8384-8388.
307. Ramirez M.M., Fraher L.J., Goltzman D., Hendy G.N., Matthews S.G., Sangha R., Challis J.R. Immunoreactive parathyroid hormone-related protein: its association with preterm labor. Eur. J. Obstet. Gynecol. Reprod. Biol. 1995, 63:21-26.
308. Curtis N.E., King R.G., Moseley J.M., Ho P.W., Rice G.E., Wlodek M.E. Intrauterine expression of parathyroid hormone-related protein in normal and pre-eclamptic pregnancies. Placenta 1998, 19:595-601.
309. Ferguson J.E., Seaner R.M., Bruns D.E., Iezzoni J.C., Bruns M.E. Expression and specific immunolocalization of the human parathyroid hormone/parathyroid hormone-related protein receptor in the uteroplacental unit. Am. J. Obstet. Gynecol. 1998, 179:321-329.
310. Curtis N.E., King R.G., Moseley J.M., Ho P.W., Rice G.E., Wlodek M.E. Intrauterine expression of parathyroid hormone-related protein in normal and pre-eclamptic pregnancies. Placenta 1998, 19:595-601.
311. Hirota Y., Anai T., Miyakawa I. Parathyroid hormone-related protein levels in maternal and cord blood. Am. J. Obstet. Gynecol. 1997, 177:702-706.
312. Bucht E., Rong H., Bremme K., Granberg B., Rian E., Torring O. Midmolecular parathyroid hormone-related peptide in serum during pregnancy, lactation and in umbilical cord blood. Eur. J. Endocrinol. 1995, 132:438-443.
313. Papantoniou N.E., Papapetrou P.D., Antsaklis A.J., Kontoleon P.E., Mesogitis S.A., Aravantinos D. Circulating levels of immunoreactive parathyroid hormone-related protein and intact parathyroid hormone in human fetuses and newborns. Eur. J. Endocrinol. 1996, 134:437-442.
314. Strid H., Bucht E., Jansson T., Wennergren M., Powell T.L. ATP dependent Ca(2+) transport across Basal membrane of human syncytiotrophoblast in pregnancies complicated by intrauterine growth restriction or diabetes. Placenta 2003, 24:445-452.
315. Ahima R.S., Saper C.B., Flier J.S., Elmquist J.K. Leptin regulation of neuroendocrine systems. Front. Neuroendocrinol. 2000, 21:263-307.
316. Masuzaki H., Ogawa Y., Sagawa N., Hosoda K., Matsumoto T., Mise H., Nishimura H., Yoshimasa Y., Tanaka I., Mori T., Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat. Med. 1997, 3:1029-1033.
317. Akerman F., Lei Z.M., Rao C.V. Human umbilical cord and fetal membranes co-express leptin and its receptor genes. Gynecol. Endocrinol. 2002, 16:299-306.
318. Mise H., Sagawa N., Matsumoto T., Yura S., Nanno H., Itoh H., Mori T., Masuzaki H., Hosoda K., Ogawa Y., Nakao K. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J. Clin. Endocrinol. Metab. 1998, 83:3225-3229.
319. Lepercq J., Cauzac M., Lahlou N., Timsit J., Girard J., Auwerx J., Hauguel-de Mouzon S. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998, 47:847-850.
320. Tartaglia L.A. The leptin receptor. J. Biol. Chem. 1997, 272:6093-6096.
321. Hoggard N., Hunter L., Duncan J.S., Williams L.M., Trayhurn P., Mercer J.G. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc. Natl. Acad. Sci. U S A 1997, 94:11073-11078.
322. Henson M.C., Swan K.F., O'Neil J.S. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet. Gynecol. 1998, 92:1020-1028.
323. Bodner J., Ebenbichler C.F., Wolf H.J., Muller-Holzner E., Stanzl U., Gander R., Huter O., Patsch J.R. Leptin receptor in human term placenta: in situ hybridization and immunohistochemical localization. Placenta 1999, 20:677-682.
324. Linnemann K., Malek A., Sager R., Blum W.F., Schneider H., Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J. Clin. Endocrinol. Metab. 2000, 85:4298-4301.
325. Hardie L., Trayhurn P., Abramovich D., Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin. Endocrinol. (Oxf). 1997, 47:101-106.
326. Yura S., Sagawa N., Mise H., Mori T., Masuzaki H., Ogawa Y., Nakao K. A positive umbilical venous-arterial difference of leptin level and its rapid decline after birth. Am. J. Obstet. Gynecol. 1998, 178:926-930.
327. Cetin I., Morpurgo P.S., Radaelli T., Taricco E., Cortelazzi D., Bellotti M., Pardi G., Beck-Peccoz P. Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term. Pediatr. Res. 2000, 48:646-651.
328. Shekhawat P.S., Garland J.S., Shivpuri C., Mick G.J., Sasidharan P., Pelz C.J., McCormick K.L. Neonatal cord blood leptin: its relationship to birth weight, body mass index, maternal diabetes, and steroids. Pediatr. Res. 1998, 43:338-343.
329. Ertl T., Funke S., Sarkany I., Szabo I., Rascher W., Blum W.F., Sulyok E. Postnatal changes of leptin levels in full-term and preterm neonates: their relation to intrauterine growth, gender and testosterone. Biol. Neonate 1999, 75:167-176.
330. Matsuda J., Yokota I., Iida M., Murakami T., Naito E., Ito M., Shima K., Kuroda Y. Serum leptin concentration in cord blood: relationship to birth weight and gender. J. Clin. Endocrinol. Metab. 1997, 82:1642-1644.
331. Laml T., Hartmann B.W., Ruecklinger E., Preyer O., Soeregi G., Wagenbichler P. Maternal serum leptin concentrations do not correlate with cord blood leptin concentrations in normal pregnancy. J. Soc. Gynecol. Investig. 2001, 8:43-47.
332. Mise H., Sagawa N., Matsumoto T., Yura S., Nanno H., Itoh H., Mori T., Masuzaki H., Hosoda K., Ogawa Y., Nakao K. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J. Clin. Endocrinol. Metab. 1998, 83:3225-3229.
333. Korbonits M., Goldstone A.P., Gueorguiev M., Grossman A.B. Ghrelin-a hormone with multiple functions. Front. Neuroendocrinol. 2004, 25:27-68.
334. Gualillo O., Caminos J., Blanco M., Garcia-Caballero T., Kojima M., Kangawa K., Dieguez C., Casanueva F. Ghrelin, a novel placental-derived hormone. Endocrinology 2001, 142:788-794.
335. Tanaka K., Minoura H., Isobe T., Yonaha H., Kawato H., Wang D.F., Yoshida T., Kojima M., Kangawa K., Toyoda N. Ghrelin is involved in the decidualization of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 2003, 88:2335-2340.
336. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002, 87:2988.
337. Makino Y., Hosoda H., Shibata K., Makino I., Kojima M., Kangawa K., Kawarabayashi T. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 2002, 39:781-784.
338. Cortelazzi D., Cappiello V., Morpurgo P.S., Ronzoni S., Nobile De Santis M.S., Cetin I., Beck-Peccoz P., Spada A. Circulating levels of ghrelin in human fetuses. Eur. J. Endocrinol. 2003, 149:111-116.
339. Farquhar J., Heiman M., Wong A.C., Wach R., Chessex P., Chanoine J.P. Elevated umbilical cord ghrelin concentrations in small for gestational age neonates. J. Clin. Endocrinol. Metab. 2003, 88:4324-4327.
340. Petraglia F., Lim A.T., Vale W. Adenosine 3′,5′-monophosphate, prostaglandins, and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. J. Clin. Endocrinol. Metab. 1987, 65:1020-1025.
341. Petraglia F., Vaughan J., Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc. Natl. Acad. Sci. U S A 1989, 86:5114-5117.
342. Petraglia F., Vaughan J., Vale W. Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. J. Clin. Endocrinol. Metab. 1990, 70:1173-1178.
343. Barnea E.R., Kaplan M. Spontaneous, gonadotropin-releasing hormone-induced, and progesterone-inhibited pulsatile secretion of human chorionic gonadotropin in the first trimester placenta in vitro. J. Clin. Endocrinol. Metab. 1989, 69:215-217.
344. Owens O.M., Ryan K.J., Tulchinsky D. Episodic secretion of human chorionic gonadotropin in early pregnancy. J. Clin. Endocrinol. Metab. 1981, 53:1307-1309.
345. Barnea E.R., Ashkenazy R., Sarne Y. The effect of dynorphin on placental pulsatile human chorionic gonadotropin secretion in vitro. J. Clin. Endocrinol. Metab. 1991, 73:1093-1098.
346. Barnea E.R., Ashkenazy R., Tal Y., Kol S., Sarne Y. Effect of beta-endorphin on human chorionic gonadotrophin secretion by placental explants. Hum. Reprod. 1991, 6:1327-1331.
347. Keelan J., Song Y., France J.T. Comparative regulation of inhibin, activin and human chorionic gonadotropin production by placental trophoblast cells in culture. Placenta 1994, 15:803-818.
348. Siler-Khodr T.M., Khodr G.S., Valenzuela G., Rhode J. GnRH effects on placental hormones during gestation. II. Progesterone, estrone, estradiol and estriol. Biol. Reprod. 1986, 34:245-254.
349. Siler-Khodr T.M., Khodr G.S., Rhode I., Vickerv B.H., Nestor I.R. Gestational age related inhibition of placental hCG, hCG and steroid hormone release in vitro by a GnRH antagonist. Placenta 1987, 8:1-14.
350. Wilson E.A., Jawad M.J. LH-RI-I suppression of human placental progesterone production. Fertil. Steril. 1980, 33:91-93.
351. Lacroix M.C., Guibourdenche J., Frendo J.L., Pidoux G., Evain-Brion D. Placental growth hormones. Endocrine 2002, 19:73-79.
352. Yamaguchi M., Endo H., Maeda T., Tahara M., Ono M., Miki N., Miyake A. Transforming growth factor-beta 1 post-transcriptionally inhibits mouse growth hormone releasing factor secretion in placenta. Biochem. Biophys. Res. Commun. 1994, 204:1206-1211.
353. de Zegher F., Vanderschueren-Lodeweyckx M., Spitz B., Faijerson Y., Blomberg F., Beckers A., Hennen G., Frankenne F. Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH. J. Clin. Endocrinol. Metab. 1990, 71:520-522.
354. Evain-Brion D., Alsat E., Mirlesse V., Dodeur M., Scippo M.L., Hennen G., Frankenne F. Regulation of growth hormone secretion in human trophoblastic cells in culture. Horm. Res. 1990, 33:256-259.
355. Patel N., Alsat E., Igout A., Baron F., Hennen G., Porquet D., Evain-Brion D. Glucose inhibits human placental GH secretion, in vitro. J. Clin. Endocrinol. Metab. 1995, 80:1743-1746.
356. Bjorklund A.O., Adamson U.K., Carlstrom K.A., Hennen G., Igout A., Lins P.E., Westgren L.M. Placental hormones during induced hypoglycemia in pregnant women with insulin-dependent diabetes mellitus: evidence of an active role for placenta in hormonal counter-regulation. Br. J. Obstet. Gynaecol. 1998, 105:649-655.
357. Macaron C., Kynel M., Rutsky L. Failure of somatostatin to affect human chorionic somaiomammotropin and human chorionic eonadotrouin secretion in vitro. J. Clin. Endocrinol. Metab. 1978, 47:141-156.
358. Artenisio A.C., Volpe A., Ragonese F., Maccarrone G., Forte F., Consolo F. Behaviour of HPL and GH plasmatic rate in pregnant women at different times of their pregnancy during dynamic tests. Horm. Metab. Res. 1980, 12:205-208.
359. Bhaumick B., Dawson E.P., Bala R.M. The effects of insulin-like growth factor 1 and insulin on placental lactogen production by human term placental explants. Biochem. Biophys. Res. Commun. 1987, 144:674-682.
360. Morrish D.W., Bhardwaj D., Dabbagh L.K., Marusyk H., Siy O. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J. Clin. Endocrinol. Metab. 1987, 65:1282-1290.
361. Lonberg U., Damm P., Andersson A.M., Main K.M., Chellakooty M., Lauenborg J., Skakkebaek N.E., Juul A. Increase in maternal placental growth hormone during pregnancy and disappearance during parturition in normal and growth hormone-deficient pregnancies. Am. J. Obstet. Gynecol. 2003, 188:247-251.
362. Verhaeghe J., Bougoussa M., Van Herck E., de Zegher F., Hennen G., Igout A. Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency. Clin. Endocrinol. (Oxf). 2000, 53:645-647.
363. Caufriez A., Frankenne F., Hennen G., Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am. J. Physiol. 1993, 265:E572-E577.
364. Petraglia F., Sutton S., Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am. J. Obstet. Gynecol. 1989, 160:247-251.
365. Cooper E.S., Greer I.A., Brooks A.N. Placental proopiomelanocortin gene expression, adrenocorticotropin tissue concentrations, and immunostaining increase throughout gestation and are unaffected by prostaglandins, antiprogestins, or labor. J. Clin. Endocrinol. Metab. 1996, 81:4462-4469.
366. Petraglia F., Florio P., Benedetto C., Marozio L., Di Blasio A.M., Ticconi C., Piccione E., Luisi S., Genazzani A.R., Vale W. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J. Clin. Endocrinol. Metab. 1999, 84:1420-1423.
367. Sasaki A., Shinkawa O., Yoshinaga K. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans. J. Clin. Invest. 1989, 84:1997-2001.
368. Chan E.C., Smith R., Lewin T., Brinsmead M.W., Zhang H.P., Cubis J., Thornton K., Hurt D. Plasma corticotropin releasing hormone, β-endorphin and cortisol inter-relationship during human pregnancy. Acta Endocrinol. 1993, 128:339-344.
369. Smith R., Mesiano S., Chan E.C., Brown S., Jaffe R.B. Corticotropin-releasing hormone directly and preferentially stimulated dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J. Clin. Endocrinol. Metab. 1998, 83:2916-2920.
370. Kaufmann P., Castellucci M. Extravillous trophoblast in the human placenta. A review. Trophoblast Res. 1997, 10:21-65.
371. Hamilton G.S., Lysiak J.J., Han V.K.M., Lala P.K. Autocrine-paracrine regulation of human trophoblast invasiveness by IGF-II and IGFBP-1. Exp. Cell. Res. 1998, 244:147-156.
372. Bass K.E., Morrish D., Roth I., Bhardwaj D., Taylor R., Zhou Y., Fisher S.J. Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process. Dev. Biol. 1994, 164:550-561.
373. Chakraborty C., Barbin Y.P., Chakrabarti S., Chidiac P., Dixon S.J., Lala P.K. Endothelin-1 promotes migration and induces elevation of [Ca2+]i and phosphorylation of MAP kinase of a human extravillous trophoblast cell line. Mol. Cell. Endocrinol. 2003, 201:63-73.
374. Caniggia I., Lye S.J., Cross J.C. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997, 138:3976-3986.
375. Athanassiades A., Hamilton G.S., Lala P.K. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol. Reprod. 1998, 59:643-654.
376. Athanassiades A., Lala P.K. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998, 19:465-473.
377. Foidart J.M., Hustin J., Dubois M., Schaaps J.P. The human placenta becomes haemochorial at the 13th week of pregnancy. Int. J. Dev. Biol. 1992, 36:451-453.
378. Caniggia I., Taylor C.V., Ritchie J.W., Lye S.J., Letarte M. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 1997, 138:4977-4988.
379. Shi Q.J., Lei Z.M., Rao C.V., Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 1993, 132:1387-1395.
380. Yang M., Lei Z.M., Rao C.V. The central role of human chorionic gonadotropin in the formation of human placental syncytium. Endocrinology 2003, 144:1108-1120.
381. Morrish D.W., Bhardwaj D., Paras M.T. Transforming growth factor beta 1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology 1991, 129:22-26.
382. Reynolds L.P., Redmer D.A. Angiogenesis in the placenta. Biol. Reprod. 2001, 64:1033-1040.
383. Dumont D.J., Fong G.H., Puri M.C., Gradwohl G., Alitalo K., Breitman M.L. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 1995, 203:80-92.
384. Grimwood J., Bicknell R., Rees M.C. The isolation, characterization and culture of human decidual endothelium. Hum. Reprod. 1995, 10:2142-2148.
385. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70.
386. Shalabi F., Rossant J., Yamaguchi T.P., Gertenstein M., Wu X-F, Breitman M., Schuh A.C. Failure of blood island formation and vasculogenesis in flk-1 deficient mice. Nature 1995, 376:62.
387. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
388. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
389. Zheng J., Vagnoni K.E., Bird I.M., Magness R.R. Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type-1 receptors in the ovine placenta during the third trimester of pregnancy. Biol. Reprod. 1997, 56:1189-1197.
390. Toth P., Li X., Rao C.V. Expression of functional human chorionic gonadotropin (hCG)/luteinizing hormone receptor gene in human uterine arteries. J. Clin. Endocrinol. Metab. 1994, 79:307-315.
391. Zygmunt M., Herr F., Keller-Schoenwetter S., Kunzi-Rapp K., Munstedt K., Rao C.V., Lang U., Preissner K.T. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J. Clin. Endocrinol. Metab. 2002, 87:5290-5296.
392. Boura A.L., Walters W.A., Read M.A., Leitch I.M. Autacoids and control of human placental blood flow. Clin. Exp. Pharmacol. Physiol. 1994, 21:737-748.
393. Poston L., McCarthy A.L., Ritter J.M. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol. Ther. 1995, 65:215-239.
394. Hermus A.R., Pieters G.F., Willemsen J.J., Ross H.A., Smals A.G., Benraad T.J., Kloppenborg P.W. Hypotensive effects of ovine and human corticotrophin-releasing factors in man. Eur. J. Clin. Pharmacol. 1987, 31:531-534.
395. Jain V., Shi S.Q., Vedernikov Y.P., Saade G.R., Chwalisz K., Garfield R.E. In vivo effects of corticotropin-releasing factor in pregnant rats. Am. J. Obstet. Gynecol. 1998, 178:186-191.
396. Jain V., Vedernikov Y.P., Saade G.R., Chwalisz K., Garfield R.E. Endothelium-dependent and - independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J. Pharmacol. Exp. Ther. 1999, 288:407-413.
397. Sue-Tang A., Bocking A.D., Brooks A.N., Hooper S., White S.E., Jacobs R.A., Fraher L.J., Challis J.R. Effects of restricting uteroplacental blood flow on concentrations of corticotrophin-releasing hormone, adrenocorticotrophin, cortisol, and prostaglandin E2 in the sheep fetus during late pregnancy. Can. J. Physiol. Pharmacol. 1992, 70:1396-1402.
398. Gagnon R., Murotsuki J., Challis J.R., Fraher L., Richardson B.S. Fetal sheep endocrine responses to sustained hypoxemic stress after chronic fetal placental embolization. Am. J. Physiol. 1997, 272:E817-E823.
399. Florio P., Severi F.M., Fiore G., Micheli L., Bocchi C., Nencini C., Pezzani I., Giorgi G., Petraglia F. Impaired uterine artery blood flow at mid gestation and low levels of maternal plasma corticotropin-releasing factor. J. Soc. Gynecol. Investig. 2003, 10:294-297.
400. Clifton V.L., Read M.A., Boura A.L., Robinson P.J., Smith R. Adrenocorticotropin causes vasodilatation in the human fetal-placental circulation. J. Clin. Endocrinol. Metab. 1996, 81:1406-1410.
401. Clifton V.L., Read M.A., Leitch I.M., Boura A.L., Robinson P.J., Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J. Clin. Endocrinol. Metab. 1994, 79:666-669.
402. Clifton V.L., Read M.A., Leitch I.M., Giles W.B., Boura A.L., Robinson P.J., Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation, involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J. Clin. Endocrinol. Metab. 1995, 80:2888-2893.
403. Simoncini T., Apa R., Reis F.M., Miceli F., Stomati M., Driul L., Lanzone A., Genazzani A.R., Petraglia F. Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J. Clin. Endocrinol. Metab. 1999, 84:2802-2806.
404. Torpy D.J., Webster E.L., Zachman E.K., Aguilera G., Chrousos G.P. Urocortin and inflammation: confounding effects of hypotension on measures of inflammation. Neuroimmunomodulation 1999, 6:182-186.
405. Leitch I.M., Boura A.L., Botti C., Read M.A., Walters W.A., Smith R. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J. Clin. Endocrinol. Metab. 1998, 83:4510-4513.
406. Fallgren B., Edvinsson L., Ekblad E., Ekman R. Involvement of perivascular neuropeptide Y nerve fibres in uterine arterial vasoconstriction in conjunction with pregnancy. Regul. Pept. 1989, 24:119-130.
407. Fried G., Hokfelt T., Lundberg J.M., Terenius L., Hamberger L. Neuropeptide Y and noradrenaline in human uterus and myometrium during normal and preeclamptic pregnancy. Hum. Reprod. 1986, 1:359-364.
408. Shirahase H., Kanda M., Kurahashi K., Nakamura S. Endothelium-dependent relaxation followed by contraction mediated by NK(1) receptors in precontracted rabbit intrapulmonary arteries. Br. J. Pharmacol. 2000, 129:937-942.
409. MacLean M.R., Templeton A.G.B., McGrath J.C. The influence of endothelin-1 on human feto-placental blood vessels: a comparison with 5-hydroxytryptamine. Br. J. Pharmacol. 1992, 106:937-941.
410. Sabry S., Mondon F., Levy M., Ferré F., Dinh-Xuan A.T. Endothelial modulation of vasoconstrictor responses to endothelin-1 in human placental stem villi small arteries. Br. J. Pharmacol. 1995, 115:1038-1042.
411. Myatt L., Bewer A.S., Brockman D.E. The comparative effects of big endothelin-1, endothelin-1, and endothelin-3 in the human placental circulation. Am. J. Obstet. Gynecol. 1992, 167:1651-1656.
412. Sand A.E., Andersson E., Fried G. Effects of nitric oxide donors and inhibitors of nitric oxide signalling on endothelin- and serotonin-induced contractions in human placental arteries. Acta Physiol. Scand. 2002, 174:217-223.
413. Hoeldtke N.J., Wagner R.K., Calhoun B.C., Hume R.F. Vasodilatory response of fetoplacental vasculature to adrenomedullin after constriction with the thromboxane sympathomimetic U46619. Am. J. Obstet. Gynecol. 2000, 183:1573-1578.
414. Jerat S., Morrish D.W., Davidge S.T., Kaufman S. Effect of adrenomedullin on placental arteries in normal and preeclamptic pregnancies. Hypertension 2001, 37:227-231.
415. Takahashi Y., De Vroomen M., Gournay V., Roman C., Rudolph A.M., Heymann M.A. Mechanisms of adrenomedullin-induced increase of pulmonary blood flow in fetal sheep. Pediatr. Res. 1999, 45:276-281.
416. Eguchi S., Hirata Y., Kano H., Sato K., Watanabe Y., Watanabe T.X., Nakajima K., Sakakibara S., Marumo F. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett. 1994, 340:226-230.
417. Kohno M., Kano H., Horio T., Yokokawa J., Yasunari K., Takeda T. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension 1995, 25:1185-1190.
418. Fiscus R.R., Wang X., Hao H. hCGRP8-37 antagonizes vasodilations and cAMP responses to rat CGRP in rat caudal artery. Ann. N Y Acad. Sci. 1992, 657:513-515.
419. Fiscus R.R., Zhou H.L., Wang X., Han C., Ali S., Joyce C.D., Murad F. Calcitonin gene-related peptide (CGRP)-induced cyclic AMP, cyclic GMP and vasorelaxant responses in rat thoracic aorta are antagonized by blockers of endothelium-derived relaxant factor (EDRF). Neuropeptides 1991, 20:133-143.
420. Mandsager N.T., Brewer A.S., Myatt L. Vasodilator effects of parathyroid hormone, parathyroid hormone-related protein, and calcitonin gene-related peptide in the human fetal-placental circulation. J. Soc. Gynecol. Investig. 1994, 1:19-24.
421. Firth K.F., Pipkin F.B. Human alpha- and beta-calcitonin gene-related peptides are vasodilators in human chorionic plate vasculature. Am. J. Obstet. Gynecol. 1989, 161:1318-1319.
422. Gangula P.R., Supowit S.C., Wimalawansa S.J., Zhao H., Hallman D.M., DiPette D.J., Yallampalli C. Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy. Hypertension 1997, 29:248-253.
423. Valdermarsson S., Edvinsson L., Hedner P., Ekman R. Hormonal influence on CGRP in man: Effects of sex differences and contraceptive pills. Scand. J. Clin Lab. Invest. 1990, 385-388.
424. Naghashpour M., Dahl G. Sensitivity of myometrium to CGRP varies during mouse estrous cycle and in response to progesterone. Am. J. Physiol. Cell. Physiol. 2000, 278:C561-C569.
425. Gangula P.R., Dong Y.L., Wimalawansa S.J., Yallampalli C. Infusion of pregnant rats with calcitonin gene-related peptide (CGRP)(8-37), a CGRP receptor antagonist, increases blood pressure and fetal mortality and decreases fetal growth. Biol. Reprod. 2002, 67:624-629.
426. Gangula P.R., Wimalawansa S.J., Yallampalli C. Pregnancy and sex steroid hormones enhance circulating calcitonin gene-related peptide concentrations in rats. Hum. Reprod. 2000, 15:949-953.
427. Gangula P.R., Zhao H., Wimalawansa S.J., Supowit S.C., DiPette D.J., Yallampalli C. Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol. Reprod. 2001, 64:1776-1783.
428. Nickols G.A., Nickols M.A., Helwig J.J. Binding of parathyroid hormone and parathyroid hormone-related protein to vascular smooth muscle of rabbit renal microvessels. Endocrinology 1990, 126:721-727.
429. Mandsager N.T., Brewer A.S., Myatt L. Vasodilator effects of parathyroid hormone, parathyroid hormone-related protein, and calcitonin gene-related peptide in the human fetal-placental circulation. J. Soc. Gynecol. Investig. 1994, 1:19-24.
430. Seckl M.J., Fisher R.A., Salerno G., Rees H., Paradinas F.J., Foskett M., Newlands E.S. Choriocarcinoma and partial hydatidiform moles. Lancet 2000, 356:36-39.
431. Lewis J.L. Diagnosis and management of gestational trophoblastic disease. Cancer 1993, 71:1639-1647.
432. McCluggage W.G., Ashe P., McBride H., Maxwell P., Sloan J.M. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 1998, 32:252-256.
433. Florio P., Severi F.M., Cobellis L., Danero S., Bome A., Luisi S., Petraglia F. Serum activin A and inhibin A. New clinical markers for hydatidiform mole. Cancer 2002, 94:2618-2622.
434. Knight G.J., Palomaki G.E. Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome. Clin. Lab. Med. 2003, 23:531-551.
435. Wald N.J., Rodeck C., Hackshaw A.K., Rudnicka A. SURUSS in perspective. BJOG 2004, 111:521-531.
436. Aitken D.A., Wallace E.M., Crossley J.A., Swanston I.A., van Pareren Y., van Maarle M., Groome N.P., Macri J.N., Connor J.M. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N. Engl. J. Med. 1996, 334:1231-1236.
437. Haddow J.E., Palomaki G.E., Knight G.J., Williams J., Miller W.A., Johnson A. Screening of maternal serum for fetal Down's syndrome in the first trimester. N. Engl. J. Med. 1998, 338:955-961.
438. Nicolaides K.H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am. J. Obstet. Gynecol. 2004, 191:45-67.
439. National High Blood Pressure Education Program Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. 2000, 183:S1-S22.
440. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56.
441. Lambert-Messerlian G.M., Silver H.M., Petraglia F., Luisi S., Pezzani I., Maybruck W.M., Hogge W.A., Hanley-Yanez K., Roberts J.M., Neveux L.M., Canick J.A. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. J. Soc. Gynecol. Investig. 2000, 7:170-174.
442. Muttukrishna S., North R.A., Morris J., Schellenberg J.C., Taylor R.S., Asselin J., Ledger W., Groome N., Redman C.W. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum. Reprod. 2000, 15:1640-1645.
443. Albaiges G., Missfelder-Lobos H., Lees C., Parra M., Nicolaides K.H. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet. Gynecol. 2000, 96:559-564.
444. Florio P., Reis F.M., Pezzani I., Luisi S., Severi F.M., Petraglia F. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultrasound Obstet. Gynecol. 2003, 21:165-169.
445. Florio P., Imperatore A., Sanseverino F., Torricelli M., Reis F.M., Lowry P.J., Petraglia F. The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia. J. Clin. Endocrinol. Metab. 2004, 89:4673-4677.
446. Baschat A.A. Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance. Obstet. Gynecol. Surv. 2004, 59:617-627.
447. Baker D.J.P., Robinson R.J. Fetal and infant origin of adult disease. Br. Med. J. 1992, 308:171-174.
448. Haddad B., Abirached F., Louis-Sylvestre C., Le Blond J., Paniel B.J., Zorn J.R. Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation. Hum. Reprod. 1999, 14:2872-2875.
449. Smith G.C.S., Stenhouse, Crossley J.A., Aitken D.A., Cameron A.D., Connor J.M. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J. Clin. Endocrinol. Metab. 2002, 87:1762-1767.
450. Hobel C.J., Dunkel-Schetter C., Roesch S.C., Castro L.C., Arora C.P. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am. J. Obstet. Gynecol. 1999, 180:S257-S263.
451. Leung T.N., Chung T.K., Madsen G., McLean M., Chang A.M., Smith R. Elevated mid-trimester maternal corticotrophin-releasing hormone levels in pregnancies that delivered before 34 weeks. Br. J. Obstet. Gynaecol. 1999, 106:1041-1046.
452. McLean M., Bisits A., Davies J., Walters W., Hackshaw A., De Voss K., Smith R. Predicting risk of preterm delivery by secondtrimester measurement of maternal plasma corticotropin-releasing hormone and α-fetoprotein concentrations. Am. J. Obstet. Gynecol. 1999, 181:207-215.